[MBSB] QoQ Cumulative Quarter Result on 31-Mar-2013 [#1]

Stock
[MBSB] MBSB BERHAD
Announcement Date
03-May-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
31-Mar-2013 [#1]
Profit Trend
QoQ- -62.8%
YoY- 109.21%
Quarter Report
Latest QR
Upcoming QR
MBSB's Result
MBSB's Financial Summary
View:
Show?
Cumulative Result
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Revenue 2,536,090 1,815,349 1,176,773 562,475 1,831,560 1,344,035 823,355 111.26%
PBT 932,349 680,934 484,699 237,110 656,227 410,480 233,099 151.34%
Tax -334,781 -216,914 -153,450 -70,966 -209,576 -147,435 -60,031 213.49%
NP 597,568 464,020 331,249 166,144 446,651 263,045 173,068 127.92%
-
NP to SH 597,568 464,020 331,249 166,144 446,651 263,045 173,068 127.92%
-
Tax Rate 35.91% 31.86% 31.66% 29.93% 31.94% 35.92% 25.75% -
Total Cost 1,938,522 1,351,329 845,524 396,331 1,384,909 1,080,990 650,287 106.71%
-
Net Worth 2,016,288 1,916,883 1,694,852 1,606,312 1,466,473 1,335,160 1,243,197 37.91%
Dividend
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Div 161,199 78,355 - - 401,074 72,932 54,691 105.16%
Div Payout % 26.98% 16.89% - - 89.80% 27.73% 31.60% -
Equity
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Net Worth 2,016,288 1,916,883 1,694,852 1,606,312 1,466,473 1,335,160 1,243,197 37.91%
NOSH 1,611,998 1,567,105 1,480,996 1,270,214 1,215,376 1,215,549 1,215,365 20.65%
Ratio Analysis
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
NP Margin 23.56% 25.56% 28.15% 29.54% 24.39% 19.57% 21.02% -
ROE 29.64% 24.21% 19.54% 10.34% 30.46% 19.70% 13.92% -
Per Share
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
RPS 157.33 115.84 79.46 44.28 150.70 110.57 67.75 75.09%
EPS 37.07 29.61 22.37 13.08 36.75 21.64 14.24 88.90%
DPS 10.00 5.00 0.00 0.00 33.00 6.00 4.50 70.04%
NAPS 1.2508 1.2232 1.1444 1.2646 1.2066 1.0984 1.0229 14.30%
Adjusted Per Share Value based on latest NOSH - 1,270,214
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
RPS 30.74 22.01 14.27 6.82 22.20 16.29 9.98 111.26%
EPS 7.24 5.63 4.02 2.01 5.41 3.19 2.10 127.70%
DPS 1.95 0.95 0.00 0.00 4.86 0.88 0.66 105.49%
NAPS 0.2444 0.2324 0.2055 0.1947 0.1778 0.1619 0.1507 37.91%
Price Multiplier on Financial Quarter End Date
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Date 31/12/13 30/09/13 28/06/13 29/03/13 31/12/12 28/09/12 29/06/12 -
Price 2.21 2.75 3.07 2.74 2.26 2.41 2.28 -
P/RPS 1.40 2.37 3.86 6.19 1.50 2.18 3.37 -44.23%
P/EPS 5.96 9.29 13.73 20.95 6.15 11.14 16.01 -48.15%
EY 16.77 10.77 7.29 4.77 16.26 8.98 6.25 92.74%
DY 4.52 1.82 0.00 0.00 14.60 2.49 1.97 73.69%
P/NAPS 1.77 2.25 2.68 2.17 1.87 2.19 2.23 -14.23%
Price Multiplier on Announcement Date
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Date 28/01/14 22/10/13 31/07/13 03/05/13 31/01/13 05/11/12 30/08/12 -
Price 2.13 2.82 3.10 2.80 2.26 2.28 2.30 -
P/RPS 1.35 2.43 3.90 6.32 1.50 2.06 3.40 -45.88%
P/EPS 5.75 9.52 13.86 21.41 6.15 10.54 16.15 -49.67%
EY 17.40 10.50 7.22 4.67 16.26 9.49 6.19 98.80%
DY 4.69 1.77 0.00 0.00 14.60 2.63 1.96 78.61%
P/NAPS 1.70 2.31 2.71 2.21 1.87 2.08 2.25 -17.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment